| Description | Argipressin, des-glynh2(9)-, can effect on aggregation of blood platelets. |
| Synonyms | 9-Deglycinamide-argipressin, (Arg8,de-Gly9)-vasopressin, DEAVP, DGAVP, 9-Des-glynh2-argipressin |
| molecular weight | 1028.17 |
| Molecular formula | C44H61N13O12S2 |
| CAS | 37552-33-3 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Golubeva MG. [Functional activity of vasopressin analog desglycinamide-arginine-vasopressin]. Izv Akad Nauk Ser Biol. 2006 May-Jun;(3):297-305. Review. Russian. PubMed PMID: 16771143. 2. Golubeva MG, Grigoreva ME, Smirnova MP. Correction of changes in ADP-induced platelet aggregation with vasopressin analogue desglycinamide-arginine-vasopressin. Bull Exp Biol Med. 2005 Aug;140(2):162-4. PubMed PMID: 16282990. 3. Reijmers LG, Hoekstra K, Burbach JP, van Ree JM, Spruijt BM. Long-term impairment of social memory in the rat after social defeat is not restored by desglycinamide-vasopressin. Neurosci Lett. 2001 Jun 15;305(3):145-8. PubMed PMID: 11403926. 4. Lança AJ, Wu PH, Jung B, Liu JF, Ng V, Kalant H. Differential increase in Fos immunoreactivity in hypothalamic and septal nuclei by arginine8-vasopressin and desglycinamide9-arginine8-vasopressin. Neuroscience. 1999;91(4):1331-41. PubMed PMID: 10391440. |